These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 30726973)

  • 41. Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.
    Binka M; Butt ZA; Wong S; Chong M; Buxton JA; Chapinal N; Yu A; Alvarez M; Darvishian M; Wong J; McGowan G; Torban M; Gilbert M; Tyndall M; Krajden M; Janjua NZ
    World J Gastroenterol; 2018 Mar; 24(11):1216-1227. PubMed ID: 29568202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
    Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
    Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
    Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; McNaughton AL; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; DeBeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vickerman P;
    Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):533-552. PubMed ID: 36996853
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and recurrence of bacteraemia in hospitalised people who inject drugs - a single Centre retrospective cohort study in Denmark.
    Thønnings S; Jansåker F; Sundqvist C; Thudium RF; Nielsen SD; Knudsen JD
    BMC Infect Dis; 2020 Aug; 20(1):634. PubMed ID: 32847528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
    Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
    BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.
    Bundle N; Balasegaram S; Parry S; Ullah S; Harris RJ; Ahmad K; Foster GR; Tong CY; Orkin C
    Euro Surveill; 2019 Jul; 24(27):. PubMed ID: 31290390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Seroprevalence survey of Egyptian tourism workers for hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and Treponema pallidum infections: association of hepatitis C virus infections with specific regions of Egypt.
    el-Sayed NM; Gomatos PJ; Rodier GR; Wierzba TF; Darwish A; Khashaba S; Arthur RR
    Am J Trop Med Hyg; 1996 Aug; 55(2):179-84. PubMed ID: 8780457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology, responses, and way forward: the silent epidemic of viral hepatitis and HIV coinfection in Vietnam.
    Sereno L; Mesquita F; Kato M; Jacka D; Nguyen TT; Nguyen TN
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(5):311-20. PubMed ID: 22828983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C infection among injection drug users in Stockholm Sweden: prevalence and gender.
    Lidman C; Norden L; Kåberg M; Käll K; Franck J; Aleman S; Birk M
    Scand J Infect Dis; 2009; 41(9):679-84. PubMed ID: 19521924
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High Rates of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus Infections and Uncommon HBV Genotype/Subtype and HCV Subtype Distributions among Transgender Individuals in Surabaya, Indonesia.
    Hadikusumo AA; Utsumi T; Amin M; Khairunisa SQ; Istimagfirah A; Wahyuni RM; Lusida MI; Soetjipto ; Rianto E; Juniastuti ; Hayashi Y
    Jpn J Infect Dis; 2016 Nov; 69(6):493-499. PubMed ID: 27000450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bloodborne virus infections among drug users in Ireland: a retrospective cross-sectional survey of screening, prevalence, incidence and hepatitis B immunisation uptake.
    Grogan L; Tiernan M; Geogeghan N; Smyth B; Keenan E
    Ir J Med Sci; 2005; 174(2):14-20. PubMed ID: 16094907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases.
    Mohamed HI; Saad ZM; Abd-Elreheem EM; Abd-ElGhany WM; Mohamed MS; Abd Elnaeem EA; Seedhom AE
    J Infect Public Health; 2013 Jun; 6(3):186-95. PubMed ID: 23668463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan.
    Ruzibakiev R; Kato H; Ueda R; Yuldasheva N; Hegay T; Avazova D; Kurbanov F; Zalalieva M; Tuichiev L; Achundjanov B; Mizokami M
    Intervirology; 2001; 44(6):327-32. PubMed ID: 11805437
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
    Sambai BC; Kingston H; Monroe-Wise A; Mbogo L; Juma E; Ludwig-Barron N; Guthrie BL; Bukusi D; Chohan BH; Scott J; Bosire R; Dunbar M; Macharia P; Masyuko S; Sinkele W; Herbeck JT; Farquhar C
    BMC Infect Dis; 2022 Jan; 22(1):73. PubMed ID: 35062890
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest Connecticut.
    Grau LE; Zhan W; Heimer R
    Drug Alcohol Rev; 2016 Sep; 35(5):628-36. PubMed ID: 27073014
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Yang RR; Gui X; Chen XY; Zhu Y
    J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran.
    Moradi G; Hajarizadeh B; Rahmani K; Mohamadi-Bolbanabad A; Darvishi S; Zareie B; Zavareh FA; Sharafi H; Alavian SM; Ramazani R; Eftekhar M; Radfar SR; Piroozi B; Gouya MM
    Int J Drug Policy; 2019 Nov; 73():129-134. PubMed ID: 31654935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B and C Virus Infections Among Human Immunodeficiency Virus-Infected People Who Inject Drugs in Lahore, Pakistan.
    Mansha S; Imran M; Shah AMUH; Jamal M; Ahmed F; Atif M; Saleem M; Safi SZ; Fatima Z; Bilal Waqar A
    Viral Immunol; 2017 Jun; 30(5):366-370. PubMed ID: 28346804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.